Hub : Traits :

Comparative body size at age 10

1512 significantly associated models · 326 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	959842	2404256	2	1	4.0e-08	2.2e-07	1.4e-01	92	NADK
2	1	5611729	7016109	2	1	5.1e-08	1.3e-11	3.4e-07	43	DNAJC11
3	1	15154630	16613660	1	1	1.8e-08	2.3e-06	9.2e-01	100	DNAJC16
4	1	28823671	30246262	1	1	1.7e-07	3.1e-06	1.8e-01	92	MECR
5	1	53996718	55567410	1	1	1.2e-07	1.9e-09	1.9e-03	73	SSBP3
6	1	61448835	63322743	2	2	2.9e-08	1.4e-10	7.8e-01	100	INADL TM2D1
7	1	65189751	66803080	2	1	5.3e-13	1.4e-12	7.0e-04	77	LEPR
8	1	71163715	73435171	1	1	9.6e-27	8.9e-29	7.4e-06	84	NEGR1
9	1	73974388	75922251	2	2	5.7e-12	7.9e-61	6.1e-44	29	FPGT TYW3
10	1	109316076	110733794	3	2	3.5e-10	1.4e-08	4.7e-01	98	AMIGO1 ATXN7L2
11	1	112312154	113857970	2	1	1.2e-07	1.3e-06	6.7e-02	86	ST7L
12	1	155172725	156572984	1	1	1.1e-07	2.1e-07	3.4e-01	97	RIT1
13	1	177195050	178753162	5	2	2.5e-27	3.7e-116	1.2e-70	40	RASAL2-AS1 RP11-568K15.1
14	1	204982713	206329620	5	1	4.2e-10	2.1e-09	1.0e+00	100	PM20D1
15	2	15703	1384725	4	8	8.9e-16	5.0e-83	NaN	NaN	AC092159.2 SH3YL1 TMEM18
16	2	23604114	26088769	11	8	1.4e-114	2.1e-100	NaN	NaN	ADCY3 EFR3B FAM228B NCOA1 POMC
17	2	61059010	61613261	1	1	1.3e-07	6.8e-08	4.4e-02	86	KIAA1841
18	2	66927859	68326904	1	1	2.9e-08	3.5e-09	3.0e-03	75	ETAA1
19	2	96669134	97176634	1	1	5.0e-08	2.0e-07	5.1e-01	98	TMEM127
20	2	160095086	161610478	1	1	1.9e-08	8.8e-07	6.0e-03	69	PLA2R1
21	2	187360440	189113345	2	1	6.8e-08	3.4e-08	1.0e+00	100	CALCRL
22	2	206159496	207637397	2	1	7.6e-10	9.6e-13	2.4e-07	48	GPR1
23	2	207696167	209165083	1	1	1.4e-07	7.1e-07	7.2e-03	71	CREB1
24	2	241477073	242953866	1	1	1.2e-07	5.5e-06	5.7e-01	98	HDLBP
25	3	10617048	12457119	2	1	1.2e-14	2.6e-14	8.2e-04	81	ATG7
26	3	46919379	49035885	4	1	1.9e-09	4.2e-09	1.4e-01	94	CSPG5
27	3	49615624	51320800	10	1	1.8e-11	4.0e-08	1.6e-03	67	RASSF1
28	3	84317575	86808226	1	1	3.7e-16	5.3e-18	2.2e-06	70	CADM2
29	3	87495550	88911119	2	1	3.5e-09	7.2e-09	1.0e+00	100	C3orf38
30	3	137733141	138296968	1	1	4.4e-08	5.0e-10	2.5e-03	76	TXNDC6
31	3	140514022	142017527	1	1	2.0e-09	5.4e-11	7.2e-04	73	RASA2
32	4	55598706	57110821	1	1	1.2e-07	6.7e-06	1.6e-01	90	CLOCK
33	5	63328721	64762465	1	2	1.5e-08	6.0e-14	1.1e-05	66	SREK1IP1
34	5	74115338	75704085	2	1	2.3e-08	1.0e-08	2.3e-03	72	POLK
35	5	175819032	177138298	1	1	6.9e-08	9.9e-07	3.4e-01	96	FGFR4
36	6	34065982	36158878	2	2	1.3e-08	7.3e-08	1.6e-02	80	TEAD3 UHRF1BP1
37	6	41042590	42443108	2	1	2.3e-10	1.5e-11	1.0e+00	100	FRS3
38	6	42496457	43892938	2	2	3.5e-08	8.4e-07	2.2e-01	94	CRIP3 DNPH1
39	6	52815766	54379332	2	2	1.5e-07	9.0e-12	5.7e-05	65	C6orf142 KLHL31
40	6	104706579	106230491	1	1	2.9e-09	1.1e-08	5.2e-02	88	LIN28B
41	7	32470370	34339347	1	1	1.6e-10	3.2e-07	3.2e-01	96	BBS9
42	7	75913086	77370662	1	1	2.5e-08	8.3e-08	1.7e-01	94	DTX2P1-UPK3BP1-PMS2P11
43	7	92169872	93683737	1	1	4.4e-09	2.7e-16	4.9e-10	42	CCDC132
44	7	101412077	102807435	1	1	3.3e-08	1.3e-06	1.2e-01	89	LRWD1
45	7	138121329	139565916	1	1	3.1e-08	8.4e-09	1.0e+00	100	TTC26
46	8	8092025	12973575	32	12	5.6e-14	1.9e-13	NaN	NaN	AC087269.1 AF131215.2 AF131215.9 AMAC1L2 FAM86B3P FLJ10661 MFHAS1 MSRA PINX1 SGK223 TDH
47	8	38025175	38574366	1	1	1.1e-07	2.9e-09	6.9e-03	79	FGFR1
48	8	40875503	41413018	1	1	2.5e-07	2.8e-08	1.5e-02	81	SFRP1
49	9	95502571	96913764	3	3	2.8e-13	3.2e-17	1.4e-02	92	FAM120AOS PHF2 RP11-165J3.6
50	9	97828471	99324377	3	1	5.6e-09	5.0e-12	1.2e-04	69	C9orf130
51	10	70696908	71213650	1	1	3.0e-08	2.2e-08	8.8e-03	78	SUPV3L1
52	10	120954350	122399277	1	1	1.4e-07	1.3e-07	5.6e-02	87	SEC23IP
53	11	26818083	29054545	2	2	2.4e-12	2.7e-17	2.7e-04	82	LIN7C METTL15
54	11	46543524	48783497	17	7	8.1e-24	3.0e-18	NaN	NaN	ACP2 C1QTNF4 FNBP4 MADD PTPMT1
55	11	64669105	66456387	9	1	1.6e-11	5.4e-11	3.0e-03	80	MAP3K11
56	11	67339278	68738157	2	1	3.1e-08	4.5e-13	1.7e-06	56	C11orf24
57	11	68781070	70179848	2	1	2.7e-10	7.6e-11	1.0e+00	100	ORAOV1
58	12	48605088	51365312	20	18	9.5e-58	4.1e-82	NaN	NaN	CCDC65 CERS5 FAIM2 LIMA1 LMBR1L RP11-386G11.10 SMARCD1 TUBA1C
59	13	27300215	29410882	5	5	2.4e-12	7.2e-17	1.8e-01	98	AL137059.1 FLT3 GTF3A PAN3-AS1
60	15	23641196	24625502	1	1	1.3e-09	7.1e-09	5.7e-02	89	NDN
61	15	66998610	68825675	5	10	1.5e-22	6.1e-29	NaN	NaN	IQCH IQCH-AS1 LBXCOR1 MAP2K5
62	16	3301360	4855279	4	3	4.0e-15	1.2e-24	2.1e-13	49	ADCY9 BTBD12 RP11-462G12.1
63	16	19016966	21147999	8	2	1.7e-37	2.1e-37	1.0e+00	100	ACSM5 GPRC5B
64	16	27655848	31833122	54	2	4.6e-18	8.9e-17	1.0e+00	100	RP11-347C12.2 SH2B1
65	16	52828325	54846383	2	3	2.9e-41	8.5e-183	1.1e-106	42	AKTIP FTO
66	16	66542957	68674788	7	1	7.6e-13	8.5e-13	1.0e+00	100	ATP6V0D1
67	16	80779331	82439714	1	1	2.6e-08	5.5e-11	1.7e-04	67	CMIP
68	17	1263564	2953418	5	1	5.1e-14	1.5e-13	1.0e+00	100	SRR
69	17	34157655	35675511	6	1	2.4e-11	1.9e-10	1.0e+00	100	DHRS11
70	17	43871147	43913030	1	1	6.7e-09	6.4e-03	8.0e-02	59	KANSL1
71	18	20393480	21863589	2	1	1.8e-08	2.7e-07	7.8e-01	100	C18orf8
72	18	38837001	40365619	1	1	1.5e-07	3.0e-07	3.6e-02	83	PIK3C3
73	18	57349900	58729694	1	1	4.9e-18	2.1e-69	5.1e-54	23	MC4R
74	18	76456503	77984604	1	1	1.4e-07	3.6e-08	1.0e-02	78	NFATC1
75	19	1473344	2923263	1	1	1.3e-07	7.9e-07	9.5e-02	89	DOT1L
76	19	18451661	20313262	8	2	1.7e-10	7.7e-10	3.2e-09	7	HAPLN4 MEF2B
77	19	37464375	38861362	1	1	2.7e-07	1.7e-05	8.7e-01	100	ZNF781
78	19	47308666	47796800	1	1	7.5e-09	5.0e-17	1.2e-10	41	TMEM160
79	19	48918157	49452462	2	1	1.2e-07	2.1e-07	2.8e-01	96	NTN5
80	22	21798199	23002699	3	1	1.5e-09	2.7e-09	3.2e-01	97	PPM1F
81	22	40061683	42784201	6	4	2.5e-13	4.4e-13	1.0e+00	100	ADSL EP300 NHP2L1

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Bipolar Disorder or Schizophrenia	1.41	4	0	0.0	-0.11	8.9e-01	DNPH1 FAM86B3P HAPLN4 SGK223
Depressed Affect (Nagel 2018)	1.61	3	1	2.2	0.00	1.0e+00	FAM120AOS FNBP4 MADD
Depression (Nagel 2018)	1.57	1	1	2.2	0.00	1.0e+00	FAM120AOS
Intelligence (Savage-Jansen 2018)	1.90	12	6	13.3	0.06	8.4e-01	ACP2 AMIGO1 C1QTNF4 CCDC65 DHRS11 DNPH1 EP300 LMBR1L MADD NEGR1 SH2B1 TMEM160
Neuroticism (Nagel 2018)	1.97	9	2	4.4	-0.97	2.3e-06	CADM2 FAM120AOS FNBP4 MADD MAP2K5 MC4R NHP2L1 PTPMT1 RP11-165J3.6
Worry (Nagel 2018)	2.47	8	2	4.4	-0.98	3.4e-05	C1QTNF4 CADM2 FAM120AOS FNBP4 IQCH MADD MC4R RP11-165J3.6
Crohns Disease (2017)	1.44	4	3	6.7	0.31	6.9e-01	ADCY3 ADCY9 NTN5 SH2B1
Irritable Bowel Disease (IBD)	1.36	6	3	6.7	0.55	2.5e-01	ADCY3 KIAA1841 NADK NCOA1 SH2B1 ST7L
Ulcerative Colitis (UC)	1.10	2	1	2.2	0.00	1.0e+00	KIAA1841 SH2B1
Major Depression (MDD)	1.21	1	1	2.2	0.00	1.0e+00	NEGR1
Reaction Time	1.84	6	3	6.7	0.00	1.0e+00	ADCY3 CCDC65 KANSL1 LMBR1L PM20D1 TUBA1C
Verbal and Numeric Reasoning (VNR)	1.88	9	4	8.9	0.24	5.0e-01	ADCY3 AMIGO1 C1QTNF4 CCDC65 DHRS11 LMBR1L MADD NEGR1 SH2B1
Breast Cancer	1.79	8	4	8.9	0.75	2.0e-02	ADCY3 ADCY9 ADSL AKTIP DNPH1 FTO HAPLN4 RIT1
Prostate Cancer	1.58	2	0	0.0	0.00	1.0e+00	PM20D1 TUBA1C
Bipolar Disorder (2011)	2.31	1	1	2.2	-0.84	1.6e-01	LMBR1L
Body Mass Index (BMI) (2010)	6.69	19	11	24.4	0.94	5.7e-12	ADCY3 AKTIP AL137059.1 C1QTNF4 CERS5 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FNBP4 FTO GPRC5B IQCH IQCH-AS1 LIN7C MAP2K5 MC4R NEGR1 POLK PTPMT1 RASA2
Crohns Disease (2012)	1.18	2	0	0.0	0.00	1.0e+00	ADCY3 RIT1
Fasting Glucose	1.20	2	0	0.0	0.00	1.0e+00	FNBP4 MADD
HDL Cholesterol	1.84	5	3	6.7	-0.75	1.5e-01	ACP2 ATP6V0D1 C1QTNF4 MADD UHRF1BP1
LDL Cholesterol	1.60	5	2	4.4	-0.77	1.3e-01	AMIGO1 ATXN7L2 MEF2B NTN5 POLK
Lupus	1.75	4	1	2.2	0.98	2.7e-03	AF131215.2 AF131215.9 AMAC1L2 MFHAS1
Neuroticism (2016)	3.20	11	9	20.0	-0.97	1.2e-07	AF131215.2 AF131215.9 AMAC1L2 FAM86B3P FLJ10661 FNBP4 MFHAS1 MSRA RP11-462G12.1 SGK223 TDH
Primary Biliary Cirrhosis	1.10	1	0	0.0	0.00	1.0e+00	ZNF781
Schizophrenia (2014)	1.38	4	0	0.0	0.61	3.9e-01	DNPH1 FAM86B3P FLJ10661 SGK223
Triglycerides	1.56	1	1	2.2	0.00	1.0e+00	MEF2B
Ulcerative Colitis	1.09	1	0	0.0	0.00	1.0e+00	KIAA1841
Blood Eosinophil Count	1.32	16	11	24.4	0.09	7.0e-01	ADCY3 ATP6V0D1 HAPLN4 IQCH KIAA1841 LIN7C MAP2K5 MAP3K11 METTL15 NHP2L1 RASSF1 RP11-347C12.2 SMARCD1 TEAD3 TMEM127 TTC26
Blood Platelet Count	1.15	26	22	48.9	-0.22	2.6e-01	ACP2 C1QTNF4 C3orf38 CERS5 CRIP3 ETAA1 FNBP4 GPRC5B HAPLN4 KANSL1 LIMA1 MADD MAP3K11 NHP2L1 NTN5 ORAOV1 PHF2 POLK PTPMT1 RASSF1 RP11-462G12.1 SMARCD1 ST7L SUPV3L1 TEAD3 UHRF1BP1
Blood Red Count	0.90	15	8	17.8	-0.53	3.4e-02	ACSM5 ADSL AMIGO1 C3orf38 CERS5 CLOCK DNAJC16 DNPH1 DOT1L KANSL1 NFATC1 RASSF1 RP11-347C12.2 SH2B1 TMEM160
Blood White Count	1.39	21	13	28.9	0.22	3.0e-01	ACP2 ADCY3 BTBD12 C1QTNF4 CALCRL CERS5 FAM228B FLT3 KIAA1841 LIMA1 MAP2K5 ORAOV1 PLA2R1 PTPMT1 RP11-347C12.2 RP11-386G11.10 RP11-462G12.1 SMARCD1 SRR SUPV3L1 TEAD3
Heel T-Score	1.63	34	22	48.9	0.25	1.3e-01	ACP2 ACSM5 ADCY9 ADSL ATG7 C11orf24 CALCRL CCDC65 CERS5 CRIP3 DNAJC11 DOT1L EP300 FAIM2 FTO GPRC5B HDLBP IQCH LIMA1 LIN28B LMBR1L MADD MAP3K11 NEGR1 NFATC1 NHP2L1 POMC PTPMT1 RP11-347C12.2 RP11-462G12.1 ST7L TMEM127 TUBA1C TXNDC6
BMI	7.87	75	61	135.6	0.96	1.5e-52	AC092159.2 ACP2 ACSM5 ADCY3 ADCY9 ADSL AKTIP AL137059.1 AMIGO1 ATG7 ATXN7L2 BTBD12 C11orf24 C18orf8 C1QTNF4 C3orf38 C6orf142 CADM2 CERS5 CMIP CREB1 CSPG5 DHRS11 DNAJC11 DNAJC16 DTX2P1-UPK3BP1-PMS2P11 EFR3B EP300 FAIM2 FAM228B FGFR1 FLT3 FNBP4 FRS3 FTO GPRC5B GTF3A HAPLN4 INADL IQCH IQCH-AS1 LBXCOR1 LIN7C MADD MAP2K5 MC4R METTL15 NADK NCOA1 NEGR1 ORAOV1 PIK3C3 PM20D1 POLK POMC PTPMT1 RASA2 RASAL2-AS1 RASSF1 RIT1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SH2B1 SH3YL1 SREK1IP1 SRR SSBP3 TEAD3 TM2D1 TMEM160 TMEM18 TTC26 TYW3 UHRF1BP1
Height	1.50	50	35	77.8	-0.49	1.6e-04	ACP2 ADCY3 ADCY9 AL137059.1 ATP6V0D1 C11orf24 C18orf8 C1QTNF4 C3orf38 C9orf130 CLOCK CMIP CRIP3 DOT1L EFR3B FAIM2 FAM228B FGFR1 FGFR4 FNBP4 FRS3 GPRC5B HAPLN4 HDLBP KANSL1 LIN28B LIN7C LRWD1 MADD MAP3K11 MC4R NCOA1 NHP2L1 NTN5 PM20D1 POMC PTPMT1 RASSF1 RP11-165J3.6 RP11-386G11.10 RP11-462G12.1 SEC23IP SFRP1 SH3YL1 SMARCD1 SRR ST7L TM2D1 UHRF1BP1 ZNF781
Waist Hip Ratio (WHR)	1.59	19	13	28.9	-0.11	6.5e-01	ACSM5 BTBD12 CALCRL CLOCK CRIP3 DNPH1 DOT1L ETAA1 FGFR4 FTO GPR1 KANSL1 MAP3K11 MECR NTN5 ORAOV1 POMC RASSF1 UHRF1BP1
Systolic Blood Pressure	2.02	23	17	37.8	-0.54	6.9e-03	ACP2 ADCY3 ADCY9 ATG7 C3orf38 CADM2 CRIP3 CSPG5 DNAJC11 EFR3B FAIM2 FLT3 FNBP4 LIN7C MADD MECR METTL15 NADK NTN5 PTPMT1 SMARCD1 SRR TEAD3
Smoking Status	2.05	9	3	6.7	0.81	1.5e-03	CADM2 CSPG5 IQCH IQCH-AS1 LIN7C MAP2K5 RASSF1 SH3YL1 SRR
Allergy or Eczema	1.21	7	1	2.2	-0.62	1.4e-01	CALCRL DHRS11 MAP3K11 NEGR1 NHP2L1 SH2B1 SRR
Cardiovascular Disease	2.14	19	7	15.6	0.29	1.8e-01	ACP2 ADCY9 ATG7 C18orf8 CALCRL CRIP3 CSPG5 DNAJC11 IQCH IQCH-AS1 MADD MAP2K5 MECR NEGR1 NTN5 RP11-347C12.2 RP11-462G12.1 SMARCD1 UHRF1BP1
Hypothyroidism (self reported)	1.21	2	0	0.0	0.00	1.0e+00	NTN5 UHRF1BP1
Respiratory disease	1.30	3	1	2.2	0.41	5.9e-01	IQCH MAP2K5 NHP2L1
Type 2 Diabetes (T2D) (2018)	1.59	5	0	0.0	0.90	4.0e-02	AKTIP FNBP4 FTO PTPMT1 TXNDC6
Lung FEV1/FVC ratio	1.35	17	11	24.4	0.53	2.8e-02	ADCY3 ADSL ATP6V0D1 CALCRL DNAJC11 EP300 FGFR1 KIAA1841 NCOA1 NEGR1 NTN5 PHF2 PINX1 PM20D1 RP11-347C12.2 SREK1IP1 TTC26
Lung FVC	1.49	20	9	20.0	0.08	7.2e-01	ATP6V0D1 BTBD12 C3orf38 CERS5 DOT1L FLT3 IQCH IQCH-AS1 LIMA1 LIN28B LIN7C MAP2K5 NCOA1 RASSF1 RP11-347C12.2 SH2B1 ST7L SUPV3L1 TXNDC6 UHRF1BP1
Neuroticism	2.05	8	4	8.9	-0.98	3.4e-09	CADM2 FAM120AOS FNBP4 IQCH IQCH-AS1 MAP2K5 NHP2L1 PTPMT1
Chronotype (morning person)	1.93	7	4	8.9	0.78	4.0e-02	ADSL AKTIP AMIGO1 C1QTNF4 FTO MADD TXNDC6
Hair Pigment	0.23	15	9	20.0	-0.40	7.9e-02	ACP2 ADCY3 ADSL C11orf24 C1QTNF4 CCDC65 KANSL1 LMBR1L MADD PM20D1 PPM1F RIT1 RP11-386G11.10 TUBA1C TXNDC6
Tanning	0.28	4	3	6.7	0.77	7.2e-02	ADCY3 CADM2 EFR3B POMC
Hand grip strength (left)	2.09	14	9	20.0	-0.28	3.1e-01	ADCY3 ADSL C1QTNF4 CADM2 DOT1L FNBP4 GPRC5B LIN28B NCOA1 PINX1 PM20D1 PTPMT1 RP11-347C12.2 ZNF781
Number of treatments/medications taken	1.25	1	0	0.0	0.00	1.0e+00	LIN28B
Sensitivity / hurt feelings	2.57	8	4	8.9	-0.99	1.1e-06	AF131215.2 AF131215.9 AMAC1L2 FAM86B3P FLJ10661 MFHAS1 SGK223 TDH
Frequency of depressed mood in last 2 weeks	1.98	2	1	2.2	0.00	1.0e+00	FAM120AOS MSRA
Hearing difficulty/problems: Yes	1.45	1	1	2.2	0.00	1.0e+00	CRIP3
Relative age of first facial hair	1.70	5	2	4.4	-0.90	3.6e-02	ATG7 C18orf8 ETAA1 LIN28B TTC26
Systolic blood pressure, automated reading	2.01	15	10	22.2	0.21	4.2e-01	AF131215.2 AF131215.9 ATG7 FAIM2 FAM86B3P FLJ10661 FNBP4 MADD MFHAS1 MSRA NADK SGK223 SMARCD1 SRR TEAD3
Medication: Metformin	1.85	2	1	2.2	0.00	1.0e+00	C1QTNF4 FNBP4
Pack years adult smoking proportion	1.40	1	0	0.0	0.00	1.0e+00	SH2B1
Impedance of leg (right)	6.30	79	55	122.2	-0.92	1.2e-42	AC092159.2 ACP2 ACSM5 ADCY3 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 AMAC1L2 AMIGO1 ATG7 ATXN7L2 BTBD12 C11orf24 C1QTNF4 C6orf142 CADM2 CCDC65 CERS5 CLOCK DTX2P1-UPK3BP1-PMS2P11 EFR3B EP300 FAIM2 FAM120AOS FAM86B3P FLJ10661 FLT3 FNBP4 FRS3 FTO GPR1 GPRC5B GTF3A HAPLN4 IQCH-AS1 LBXCOR1 LIMA1 LIN28B LIN7C LMBR1L MADD MAP2K5 MAP3K11 MC4R MECR METTL15 MFHAS1 MSRA NADK NEGR1 ORAOV1 PHF2 PINX1 PM20D1 POLK POMC PPM1F RASAL2-AS1 RASSF1 RIT1 RP11-347C12.2 RP11-386G11.10 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 SH3YL1 SMARCD1 SREK1IP1 SRR TDH TEAD3 TMEM160 TMEM18 TTC26 TYW3 UHRF1BP1
Leg fat-free mass (left)	4.74	59	43	95.6	0.90	8.1e-29	AC092159.2 ACSM5 ADCY9 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 AMAC1L2 C11orf24 C18orf8 C3orf38 C6orf142 CADM2 CERS5 CREB1 DHRS11 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM86B3P FLT3 FNBP4 FRS3 FTO GPRC5B GTF3A IQCH IQCH-AS1 KANSL1 LBXCOR1 LIN28B LIN7C MADD MAP2K5 MC4R METTL15 MFHAS1 MSRA NADK NCOA1 NEGR1 ORAOV1 PM20D1 POLK RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 SSBP3 TEAD3 TM2D1 TMEM160 TMEM18 TTC26 UHRF1BP1
Trunk fat percentage	4.39	34	27	60.0	0.90	4.7e-17	ACP2 ADCY3 AKTIP AL137059.1 C18orf8 C1QTNF4 C3orf38 CERS5 DHRS11 DNAJC11 DTX2P1-UPK3BP1-PMS2P11 EFR3B FAIM2 FNBP4 FTO IQCH IQCH-AS1 LIN7C MADD MAP2K5 MC4R METTL15 NEGR1 PIK3C3 POLK POMC PTPMT1 RASAL2-AS1 RP11-347C12.2 RP11-462G12.1 SH2B1 ST7L TM2D1 UHRF1BP1
Hand grip strength (right)	1.59	12	5	11.1	-0.52	6.5e-02	ADCY3 C1QTNF4 CADM2 DOT1L FNBP4 LIN28B NCOA1 PM20D1 PTPMT1 RP11-347C12.2 SH2B1 ZNF781
Townsend deprivation index at recruitment	1.98	1	0	0.0	0.00	1.0e+00	MAP2K5
Current tobacco smoking	1.96	1	0	0.0	0.00	1.0e+00	AMAC1L2
Fed-up feelings	2.14	8	5	11.1	-0.73	2.4e-02	AF131215.2 AF131215.9 FAM86B3P FLJ10661 MFHAS1 MSRA SGK223 SH2B1
Frequency of unenthusiasm / disinterest in last 2 weeks	1.41	1	0	0.0	0.00	1.0e+00	FAM120AOS
Relative age voice broke	1.66	1	1	2.2	0.00	1.0e+00	LIN28B
Age when periods started (menarche)	4.68	24	11	24.4	-0.83	3.6e-09	ADCY3 AKTIP C1QTNF4 C3orf38 CCDC65 FAIM2 FNBP4 FPGT FTO GPRC5B HAPLN4 IQCH IQCH-AS1 LEPR LIN28B MADD MAP2K5 NEGR1 NTN5 PAN3-AS1 RASAL2-AS1 RP11-568K15.1 SSBP3 TTC26
Heel bone mineral density (BMD) T-score, automated (left)	3.21	18	11	24.4	0.91	9.0e-08	AC087269.1 AF131215.2 AF131215.9 AMAC1L2 C11orf24 CERS5 DNAJC11 EP300 FAM86B3P FLJ10661 LIN28B MADD MFHAS1 MSRA PINX1 SGK223 ST7L TDH
High blood pressure	2.64	24	10	22.2	0.54	3.5e-03	ACP2 AF131215.2 AF131215.9 AMAC1L2 ATG7 CRIP3 DNAJC11 FAM86B3P FLJ10661 FNBP4 IQCH IQCH-AS1 LBXCOR1 MADD MAP2K5 MECR MFHAS1 MSRA NEGR1 NTN5 RP11-347C12.2 SGK223 SMARCD1 SRR
Hayfever, allergic rhinitis or eczema	1.18	2	1	2.2	0.00	1.0e+00	MAP3K11 NHP2L1
Multivitamins +/- minerals	1.42	1	0	0.0	0.00	1.0e+00	PM20D1
Medication: Levothyroxine sodium	1.77	5	3	6.7	-0.72	1.7e-01	FAM86B3P FLJ10661 MFHAS1 SGK223 UHRF1BP1
Sitting height	1.45	25	17	37.8	-0.58	2.4e-03	ACP2 ADCY3 AL137059.1 C1QTNF4 C9orf130 CALCRL CMIP CRIP3 DOT1L EFR3B FAM228B FNBP4 FRS3 GTF3A HAPLN4 MADD NCOA1 NTN5 PM20D1 POMC PTPMT1 SFRP1 SMARCD1 TM2D1 UHRF1BP1
Chronic bronchitis/emphysema (father)	1.79	1	0	0.0	0.00	1.0e+00	IQCH
High blood pressure (mother)	1.58	1	0	0.0	0.00	1.0e+00	CRIP3
Body mass index (BMI)	7.48	74	53	117.8	0.96	3.7e-52	AC087269.1 AC092159.2 ACP2 ACSM5 ADCY3 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 AMAC1L2 AMIGO1 BTBD12 C18orf8 C1QTNF4 C3orf38 C6orf142 CADM2 CERS5 CREB1 CSPG5 DHRS11 DNAJC11 DTX2P1-UPK3BP1-PMS2P11 EFR3B EP300 FAIM2 FAM228B FAM86B3P FGFR1 FLJ10661 FLT3 FNBP4 FRS3 FTO GPRC5B GTF3A HAPLN4 IQCH IQCH-AS1 LBXCOR1 LIN7C MADD MAP2K5 MC4R METTL15 MFHAS1 MSRA NADK NEGR1 ORAOV1 PIK3C3 PINX1 POLK POMC PTPMT1 RASA2 RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 SH3YL1 SRR TDH TEAD3 TM2D1 TMEM160 TMEM18 TTC26 TYW3 UHRF1BP1
Impedance of leg (left)	6.18	78	53	117.8	-0.92	8.7e-41	AC092159.2 ACP2 ACSM5 ADCY3 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 AMAC1L2 AMIGO1 ATG7 ATXN7L2 BTBD12 C11orf24 C1QTNF4 C6orf142 CADM2 CERS5 CLOCK DNAJC16 DTX2P1-UPK3BP1-PMS2P11 EFR3B EP300 FAIM2 FAM120AOS FAM86B3P FLJ10661 FNBP4 FRS3 FTO GPR1 GPRC5B GTF3A HAPLN4 IQCH-AS1 LBXCOR1 LIMA1 LIN28B LIN7C LMBR1L MADD MAP2K5 MAP3K11 MC4R MECR METTL15 MFHAS1 MSRA NADK NEGR1 ORAOV1 PHF2 PINX1 PM20D1 POLK POMC PPM1F RASAL2-AS1 RASSF1 RIT1 RP11-347C12.2 RP11-386G11.10 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 SH3YL1 SMARCD1 SREK1IP1 SRR TDH TEAD3 TMEM160 TMEM18 TTC26 TYW3 UHRF1BP1
Leg predicted mass (left)	4.73	58	43	95.6	0.90	2.7e-28	AC092159.2 ACSM5 ADCY9 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 AMAC1L2 C11orf24 C18orf8 C3orf38 C6orf142 CADM2 CERS5 CREB1 DHRS11 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM86B3P FLT3 FNBP4 FRS3 FTO GPRC5B GTF3A IQCH IQCH-AS1 KANSL1 LBXCOR1 LIN28B LIN7C MADD MAP2K5 MC4R METTL15 MFHAS1 MSRA NADK NCOA1 NEGR1 ORAOV1 PM20D1 POLK RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 SSBP3 TEAD3 TM2D1 TMEM18 TTC26 UHRF1BP1
Trunk fat mass	5.07	47	30	66.7	0.89	2.2e-21	AC092159.2 ACP2 ADCY3 ADCY9 AKTIP AL137059.1 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CREB1 DHRS11 DNAJC11 DTX2P1-UPK3BP1-PMS2P11 EFR3B FAIM2 FLT3 FNBP4 FRS3 FTO GPRC5B GTF3A IQCH IQCH-AS1 KANSL1 LBXCOR1 LIN28B LIN7C MADD MAP2K5 MC4R METTL15 NEGR1 PIK3C3 POLK POMC PTPMT1 RASAL2-AS1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SH2B1 ST7L TM2D1 TMEM18 UHRF1BP1
Waist circumference	5.66	48	32	71.1	0.93	2.1e-27	AC092159.2 ADCY3 ADCY9 ADSL AKTIP AL137059.1 C18orf8 C1QTNF4 C3orf38 CADM2 CALCRL CERS5 CREB1 DHRS11 DNAJC11 DTX2P1-UPK3BP1-PMS2P11 EFR3B FAIM2 FLT3 FNBP4 FRS3 FTO GPRC5B GTF3A IQCH IQCH-AS1 KANSL1 LIN7C MADD MAP2K5 MC4R METTL15 NADK NEGR1 PIK3C3 POLK POMC PTPMT1 RASA2 RASAL2-AS1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SH2B1 TEAD3 TM2D1 TMEM18 UHRF1BP1
Number of incorrect matches in round	1.21	1	1	2.2	0.00	1.0e+00	RP11-347C12.2
Past tobacco smoking	2.65	9	4	8.9	-0.61	2.7e-02	C18orf8 CADM2 CSPG5 IQCH IQCH-AS1 MAP2K5 SH3YL1 SRR TMEM18
Alcohol usually taken with meals	1.59	2	0	0.0	0.00	1.0e+00	NEGR1 TXNDC6
Nervous feelings	4.10	17	11	24.4	-0.96	4.3e-11	AC087269.1 AF131215.2 AF131215.9 AMAC1L2 CADM2 FAM86B3P FLJ10661 IQCH LIN7C MADD MAP2K5 MFHAS1 MSRA PINX1 RASSF1 SGK223 TDH
Frequency of tenseness / restlessness in last 2 weeks	1.30	1	0	0.0	0.00	1.0e+00	FAM120AOS
Hearing difficulty/problems with background noise	1.57	3	1	2.2	0.00	1.0e+00	CRIP3 LIN28B PM20D1
Had menopause	1.06	1	0	0.0	0.00	1.0e+00	FGFR4
Forced vital capacity (FVC)	1.40	9	4	8.9	-0.92	1.4e-04	ACP2 ADCY3 C1QTNF4 CMIP FNBP4 KANSL1 MFHAS1 NCOA1 NFATC1
Heel bone mineral density (BMD) T-score, automated (right)	3.21	16	11	24.4	0.97	3.5e-10	AC087269.1 AF131215.2 AF131215.9 AMAC1L2 ATG7 C11orf24 CERS5 FAM86B3P FLJ10661 MADD MFHAS1 MSRA PINX1 SGK223 ST7L TDH
Qualifications: None of the above	1.24	4	2	4.4	0.33	6.7e-01	CSPG5 DHRS11 NEGR1 SH2B1
Financial difficulties in last 2 years	1.37	1	0	0.0	0.00	1.0e+00	FGFR4
Mouth/teeth dental problems	1.25	1	0	0.0	0.00	1.0e+00	NTN5
Allergy	1.13	2	1	2.2	0.00	1.0e+00	MAP3K11 NHP2L1
Diabetes (self-reported)	1.42	1	0	0.0	0.00	1.0e+00	POLK
Medication: Simvastatin	1.33	1	1	2.2	0.00	1.0e+00	NTN5
Fluid intelligence score	1.63	5	3	6.7	-0.36	5.5e-01	AMIGO1 C1QTNF4 DHRS11 NEGR1 SH2B1
Neuroticism score	3.88	15	12	26.7	-0.95	1.5e-08	AC087269.1 AF131215.2 AF131215.9 AMAC1L2 FAM120AOS FAM86B3P FLJ10661 FNBP4 MC4R MFHAS1 MSRA NHP2L1 PINX1 SGK223 TDH
Weight	5.42	60	44	97.8	0.92	3.3e-32	AC092159.2 ACSM5 ADCY3 ADCY9 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C18orf8 C1QTNF4 C3orf38 C6orf142 CADM2 CERS5 CREB1 DHRS11 DOT1L DTX2P1-UPK3BP1-PMS2P11 EFR3B FAIM2 FAM86B3P FLT3 FNBP4 FRS3 FTO GPRC5B GTF3A IQCH IQCH-AS1 KANSL1 LBXCOR1 LIN7C MADD MAP2K5 MC4R METTL15 MSRA NADK NEGR1 ORAOV1 PIK3C3 PM20D1 POLK POMC RASA2 RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 SSBP3 TEAD3 TM2D1 TMEM160 TMEM18 UHRF1BP1
Impedance of arm (right)	4.60	57	41	91.1	-0.90	1.2e-25	AC092159.2 ACSM5 ADSL AF131215.2 AF131215.9 AKTIP AMAC1L2 AMIGO1 C11orf24 C9orf130 CADM2 CERS5 CREB1 DHRS11 DTX2P1-UPK3BP1-PMS2P11 EP300 FAIM2 FAM86B3P FLJ10661 FTO GPR1 GPRC5B GTF3A HAPLN4 HDLBP LBXCOR1 LIMA1 LIN28B LIN7C LMBR1L MAP2K5 MAP3K11 MC4R MFHAS1 MSRA NADK NEGR1 NHP2L1 PINX1 PM20D1 POLK POMC RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH3YL1 SMARCD1 SREK1IP1 ST7L TDH TEAD3 TMEM160 TMEM18 TTC26 UHRF1BP1
Arm fat percentage (right)	6.17	50	32	71.1	0.94	3.2e-30	ACP2 ACSM5 ADCY3 AF131215.2 AKTIP AL137059.1 C18orf8 C1QTNF4 C3orf38 CERS5 DHRS11 DNAJC11 DTX2P1-UPK3BP1-PMS2P11 EFR3B FAIM2 FLT3 FNBP4 FTO GPRC5B GTF3A IQCH IQCH-AS1 KANSL1 LBXCOR1 LIN7C MADD MAP2K5 MC4R METTL15 MFHAS1 MSRA NEGR1 NFATC1 ORAOV1 PIK3C3 POLK POMC PTPMT1 RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 SRR TM2D1 TMEM18 TYW3 UHRF1BP1
Trunk fat-free mass	3.10	48	35	77.8	0.76	6.2e-12	AC092159.2 ACSM5 ADCY9 ADSL AF131215.9 AKTIP AL137059.1 C11orf24 C18orf8 C3orf38 CADM2 CERS5 CREB1 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FGFR4 FLT3 FRS3 FTO GPR1 GPRC5B GTF3A KANSL1 LBXCOR1 LIN28B LIN7C MADD MC4R METTL15 NADK NCOA1 NEGR1 ORAOV1 PINX1 PM20D1 POLK PTPMT1 RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SH2B1 TEAD3 TM2D1 TMEM18 UHRF1BP1
Hip circumference	5.39	54	36	80.0	0.91	8.9e-27	AC092159.2 ACP2 ACSM5 ADCY3 AF131215.2 AF131215.9 AKTIP AL137059.1 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CREB1 DHRS11 DOT1L DTX2P1-UPK3BP1-PMS2P11 EFR3B FAIM2 FAM86B3P FLT3 FNBP4 FRS3 FTO GPRC5B GTF3A IQCH IQCH-AS1 LBXCOR1 LIN7C MADD MAP2K5 MC4R METTL15 NADK NEGR1 ORAOV1 PIK3C3 POLK POMC PTPMT1 RASA2 RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 TEAD3 TM2D1 TMEM127 TMEM18 UHRF1BP1
Alcohol intake versus 10 years previously	1.23	2	0	0.0	0.00	1.0e+00	NEGR1 NTN5
Worrier / anxious feelings	4.22	16	12	26.7	-0.91	3.4e-07	AC087269.1 AF131215.2 AF131215.9 AMAC1L2 CADM2 DNPH1 FAM86B3P FLJ10661 MC4R MFHAS1 MSRA PINX1 RP11-462G12.1 SGK223 TDH TEAD3
Frequency of tiredness / lethargy in last 2 weeks	1.51	4	0	0.0	-0.48	5.2e-01	FAM120AOS LIN7C RP11-165J3.6 SREK1IP1
Number of live births	1.27	1	0	0.0	0.00	1.0e+00	CADM2
Forced expiratory volume in 1-second (FEV1)	1.33	9	4	8.9	-0.88	1.5e-03	AC087269.1 ADCY3 C1QTNF4 C9orf130 CMIP FLJ10661 MFHAS1 NCOA1 SGK223
Qualifications: A levels/AS levels or equivalent	1.04	1	1	2.2	0.00	1.0e+00	NEGR1
Serious illness, injury or assault of a close relative in last 2 years	1.68	1	0	0.0	0.00	1.0e+00	NTN5
Mouth/teeth dental problems: Dentures	1.65	3	1	2.2	0.00	1.0e+00	ADCY3 AF131215.2 NTN5
Asthma	1.41	3	0	0.0	0.00	1.0e+00	IQCH MAP2K5 NHP2L1
Medication: Cholesterol lowering	1.36	2	1	2.2	0.00	1.0e+00	DNAJC11 NTN5
Illnesses of mother	1.22	1	0	0.0	0.00	1.0e+00	DHRS11
Forced expiratory volume in 1-second (FEV1), Best measure	1.26	9	2	4.4	-0.85	3.4e-03	AC087269.1 ACP2 ADCY3 C1QTNF4 C9orf130 CMIP FLJ10661 MFHAS1 SGK223
Impedance of arm (left)	4.45	53	35	77.8	-0.90	1.5e-22	AC092159.2 ACSM5 ADSL AF131215.2 AF131215.9 AKTIP AMAC1L2 AMIGO1 C11orf24 C9orf130 CADM2 CERS5 DHRS11 DTX2P1-UPK3BP1-PMS2P11 EP300 FAIM2 FAM86B3P FLJ10661 FTO GPR1 GPRC5B GTF3A HAPLN4 HDLBP IQCH-AS1 LBXCOR1 LIMA1 LIN28B LIN7C MAP2K5 MAP3K11 MC4R MFHAS1 MSRA NADK NEGR1 NHP2L1 PINX1 PM20D1 POLK POMC RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH3YL1 SMARCD1 TDH TEAD3 TMEM160 TMEM18 TTC26
Arm fat mass (right)	6.62	62	45	100.0	0.95	3.3e-41	AC092159.2 ACP2 ACSM5 ADCY3 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 AMAC1L2 C18orf8 C1QTNF4 C3orf38 C6orf142 CADM2 CERS5 CREB1 DHRS11 DNAJC11 DTX2P1-UPK3BP1-PMS2P11 EFR3B FAIM2 FAM86B3P FLJ10661 FLT3 FNBP4 FRS3 FTO GPRC5B GTF3A IQCH IQCH-AS1 KANSL1 LBXCOR1 LIN7C MADD MAP2K5 MC4R METTL15 MFHAS1 MSRA NADK NEGR1 ORAOV1 PIK3C3 POLK POMC PTPMT1 RASA2 RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 SRR TEAD3 TM2D1 TMEM18 TYW3 UHRF1BP1
Trunk predicted mass	3.12	47	35	77.8	0.76	9.4e-12	AC092159.2 ADCY9 ADSL AF131215.9 AKTIP AL137059.1 C11orf24 C18orf8 C3orf38 CADM2 CERS5 CREB1 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FGFR4 FLT3 FRS3 FTO GPR1 GPRC5B GTF3A KANSL1 LBXCOR1 LIN28B LIN7C MADD MC4R METTL15 NADK NCOA1 NEGR1 ORAOV1 PINX1 PM20D1 POLK PTPMT1 RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SH2B1 TEAD3 TM2D1 TMEM18 UHRF1BP1
Standing height	1.63	35	26	57.8	-0.53	6.2e-04	AC087269.1 ACP2 ADCY3 ADCY9 AF131215.2 C1QTNF4 C9orf130 CMIP CRIP3 DOT1L EFR3B FAIM2 FGFR4 FLJ10661 FNBP4 FRS3 HAPLN4 KANSL1 LIN28B MADD MAP3K11 MC4R MFHAS1 NCOA1 PM20D1 POMC PTPMT1 RASSF1 RP11-462G12.1 SEC23IP SGK223 SH2B1 SMARCD1 TM2D1 UHRF1BP1
Tense / 'highly strung'	2.58	10	6	13.3	-0.98	7.6e-08	AF131215.2 AF131215.9 AMAC1L2 CADM2 FAM120AOS FAM86B3P FLJ10661 MFHAS1 MSRA SGK223
Seen doctor (GP) for nerves, anxiety, tension or depression	1.84	1	1	2.2	0.00	1.0e+00	NEGR1
Hair/balding pattern: Pattern 4	1.68	8	4	8.9	0.64	6.3e-02	CERS5 ETAA1 IQCH KANSL1 KIAA1841 LIMA1 SMARCD1 SRR
Birth weight of first child	1.19	1	1	2.2	0.00	1.0e+00	SUPV3L1
Peak expiratory flow (PEF)	1.46	8	4	8.9	-0.47	2.0e-01	AC087269.1 AF131215.9 C1QTNF4 FLJ10661 MFHAS1 NTN5 PM20D1 SGK223
Medication for cholesterol, blood pressure or diabetes	1.63	2	1	2.2	0.00	1.0e+00	AKTIP DNAJC11
Gout (self-reported)	1.12	1	0	0.0	0.00	1.0e+00	MAP3K11
Hypothyroidism/myxoedema (self-reported)	2.06	8	4	8.9	-0.84	4.2e-03	AF131215.9 AMAC1L2 FAM86B3P FLJ10661 MFHAS1 MSRA SGK223 UHRF1BP1
Birth weight	1.63	8	2	4.4	0.97	4.8e-05	ADCY9 LMBR1L NTN5 ORAOV1 PLA2R1 RIT1 SRR SUPV3L1
Forced vital capacity (FVC), Best measure	1.30	10	5	11.1	-0.94	2.3e-05	ACP2 ADCY3 C1QTNF4 CMIP FNBP4 MADD NCOA1 NFATC1 PTPMT1 TXNDC6
Body fat percentage	4.90	35	27	60.0	0.92	2.7e-19	ACP2 ADCY3 AKTIP AL137059.1 C18orf8 C1QTNF4 C3orf38 CERS5 DHRS11 DNAJC11 DTX2P1-UPK3BP1-PMS2P11 EFR3B FAIM2 FNBP4 FTO GTF3A IQCH IQCH-AS1 LIN7C MADD MAP2K5 MC4R METTL15 NEGR1 PIK3C3 POLK POMC PTPMT1 RASAL2-AS1 RP11-347C12.2 RP11-462G12.1 SH2B1 ST7L TM2D1 UHRF1BP1
Leg fat percentage (right)	4.73	39	26	57.8	0.95	6.5e-26	ACP2 ADCY3 AKTIP AL137059.1 C18orf8 C1QTNF4 C3orf38 CADM2 CALCRL CERS5 DHRS11 DNAJC11 DTX2P1-UPK3BP1-PMS2P11 EFR3B FAIM2 FAM228B FNBP4 FTO GTF3A IQCH IQCH-AS1 LBXCOR1 LIN7C MADD MAP2K5 MC4R METTL15 MFHAS1 NEGR1 PIK3C3 POLK POMC PTPMT1 RASAL2-AS1 RP11-347C12.2 RP11-462G12.1 SH2B1 TM2D1 UHRF1BP1
Arm fat-free mass (right)	3.81	49	36	80.0	0.84	1.7e-17	AC092159.2 ACSM5 ADCY9 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C18orf8 C3orf38 CADM2 CERS5 CREB1 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM86B3P FGFR4 FLT3 FRS3 FTO GPRC5B GTF3A IQCH-AS1 LBXCOR1 LIN7C MADD MAP2K5 MC4R MSRA NADK NCOA1 NEGR1 PINX1 PM20D1 POLK RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 TEAD3 TM2D1 TMEM18 TTC26 UHRF1BP1
Worry too long after embarrassment	2.84	9	5	11.1	-0.99	3.4e-09	AF131215.2 AF131215.9 AMAC1L2 FAM86B3P FLJ10661 IQCH MFHAS1 SGK223 TDH
Wheeze or whistling in the chest in last year	1.54	2	0	0.0	0.00	1.0e+00	LIN7C RP11-347C12.2
Number of children fathered	1.57	1	1	2.2	0.00	1.0e+00	CADM2
Qualifications: College or University degree	1.20	8	2	4.4	-0.12	7.8e-01	AMIGO1 C18orf8 CADM2 CSPG5 DHRS11 FPGT NEGR1 SH2B1
Medication: Blood pressure	1.89	1	1	2.2	0.00	1.0e+00	DNAJC11
Medication: Allopurinol	1.26	1	0	0.0	0.00	1.0e+00	MAP3K11
Mean time to correctly identify matches	1.94	6	4	8.9	0.41	2.7e-01	CCDC65 KANSL1 LMBR1L PM20D1 RP11-386G11.10 TUBA1C
Whole body fat mass	5.68	50	33	73.3	0.93	2.9e-28	AC092159.2 ACP2 ACSM5 ADCY3 ADCY9 AF131215.9 AKTIP AL137059.1 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CREB1 DHRS11 DNAJC11 DTX2P1-UPK3BP1-PMS2P11 EFR3B FAIM2 FLT3 FNBP4 FRS3 FTO GPRC5B GTF3A IQCH IQCH-AS1 KANSL1 LBXCOR1 LIN7C MADD MAP2K5 MC4R METTL15 NEGR1 PIK3C3 POLK POMC PTPMT1 RASA2 RASAL2-AS1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 TEAD3 TM2D1 TMEM18 UHRF1BP1
Leg fat mass (right)	6.19	56	37	82.2	0.94	2.8e-34	AC092159.2 ACP2 ACSM5 ADCY3 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CREB1 DHRS11 DNAJC11 DTX2P1-UPK3BP1-PMS2P11 EFR3B FAIM2 FAM86B3P FLJ10661 FLT3 FNBP4 FTO GPRC5B GTF3A IQCH IQCH-AS1 LBXCOR1 LIN7C MADD MAP2K5 MC4R METTL15 MFHAS1 MSRA NADK NEGR1 PIK3C3 POLK POMC PTPMT1 RASA2 RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 TEAD3 TM2D1 TMEM160 TMEM18 UHRF1BP1
Arm predicted mass (right)	3.82	50	35	77.8	0.85	2.0e-17	AC092159.2 ACSM5 ADCY9 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C18orf8 C3orf38 CADM2 CERS5 CREB1 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM86B3P FGFR4 FLJ10661 FLT3 FRS3 FTO GPRC5B GTF3A IQCH-AS1 LBXCOR1 LIN7C MADD MAP2K5 MC4R MSRA NADK NCOA1 NEGR1 PINX1 PM20D1 POLK RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 TEAD3 TM2D1 TMEM18 TTC26 UHRF1BP1
Pulse rate, automated reading	1.47	13	5	11.1	-0.64	5.3e-03	CALCRL CCDC65 CSPG5 GPRC5B LMBR1L NCOA1 NEGR1 NFATC1 PM20D1 RASSF1 RP11-386G11.10 TMEM127 TUBA1C
Alcohol intake frequency.	1.99	9	8	17.8	0.79	1.1e-02	C18orf8 C1QTNF4 CADM2 FNBP4 NEGR1 NTN5 PTPMT1 RP11-347C12.2 SH2B1
Comparative height size at age 10	1.59	23	16	35.6	0.09	6.7e-01	ADCY3 ADCY9 C18orf8 CMIP DOT1L EFR3B FAIM2 FGFR4 FRS3 IQCH MADD METTL15 NCOA1 NTN5 PM20D1 POMC RASAL2-AS1 RP11-462G12.1 SFRP1 SH2B1 SUPV3L1 TM2D1 TMEM18
Number of full sisters	1.28	1	0	0.0	0.00	1.0e+00	CADM2
Suffer from 'nerves'	3.71	15	11	24.4	-0.83	6.0e-05	AF131215.2 AF131215.9 C1QTNF4 CADM2 FAM86B3P FLJ10661 FNBP4 IQCH MC4R MFHAS1 MSRA PINX1 PTPMT1 SGK223 SH2B1
Overall health rating	1.50	4	0	0.0	-0.51	4.9e-01	AF131215.9 FAM120AOS RP11-165J3.6 UHRF1BP1
Hypertension (Self-reported)	2.61	25	11	24.4	0.49	1.0e-02	ACP2 ADCY9 AF131215.2 AF131215.9 AMAC1L2 ATG7 CALCRL CLOCK CRIP3 CSPG5 DNAJC11 FAM86B3P FLJ10661 IQCH IQCH-AS1 MADD MAP2K5 MECR MFHAS1 MSRA NEGR1 NTN5 SGK223 SMARCD1 SRR
Smoking status: Previous	2.37	6	1	2.2	0.71	7.1e-02	C18orf8 CADM2 IQCH IQCH-AS1 MAP2K5 TMEM18
Forced expiratory volume in 1-second (FEV1), predicted	1.50	4	1	2.2	-0.31	6.9e-01	DOT1L FRS3 LIN28B RASSF1
Whole body fat-free mass	3.79	52	38	84.4	0.84	6.3e-18	AC092159.2 ACSM5 ADCY9 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C18orf8 C3orf38 C6orf142 CADM2 CERS5 CREB1 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM86B3P FGFR4 FLT3 FRS3 FTO GPRC5B GTF3A IQCH-AS1 KANSL1 LBXCOR1 LIN28B LIN7C MADD MC4R METTL15 NADK NCOA1 NEGR1 ORAOV1 PINX1 PM20D1 POLK RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SH2B1 TEAD3 TM2D1 TMEM160 TMEM18 TTC26 UHRF1BP1
Leg fat-free mass (right)	4.58	56	43	95.6	0.90	2.3e-27	AC092159.2 ACSM5 ADCY9 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 AMAC1L2 C11orf24 C18orf8 C3orf38 C6orf142 CADM2 CERS5 CREB1 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM86B3P FLT3 FNBP4 FRS3 FTO GPRC5B GTF3A IQCH IQCH-AS1 KANSL1 LIN28B LIN7C MADD MAP2K5 MC4R METTL15 MSRA NADK NCOA1 NEGR1 ORAOV1 PHF2 PM20D1 POLK RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 SSBP3 TEAD3 TM2D1 TMEM18 TTC26 UHRF1BP1
Arm fat percentage (left)	6.28	49	33	73.3	0.94	1.9e-29	ACP2 ACSM5 ADCY3 AF131215.2 AF131215.9 AKTIP AL137059.1 C18orf8 C1QTNF4 C3orf38 CERS5 DHRS11 DNAJC11 DTX2P1-UPK3BP1-PMS2P11 EFR3B FAIM2 FLJ10661 FLT3 FNBP4 FTO GPRC5B GTF3A IQCH IQCH-AS1 LBXCOR1 LIN7C MADD MAP2K5 MC4R METTL15 MFHAS1 MSRA NEGR1 PIK3C3 POLK POMC PTPMT1 RASA2 RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 SRR TM2D1 TMEM18 UHRF1BP1
Average weekly red wine intake	1.67	1	1	2.2	0.00	1.0e+00	C18orf8
Mood swings	2.14	9	1	2.2	-0.99	3.6e-08	AF131215.2 AF131215.9 FAM86B3P FLJ10661 FNBP4 MADD MFHAS1 MSRA SGK223
Loneliness, isolation	1.49	1	0	0.0	0.00	1.0e+00	PTPMT1
Long-standing illness, disability or infirmity	1.80	3	0	0.0	0.00	1.0e+00	HDLBP IQCH NEGR1
Diabetes diagnosed by doctor	1.50	1	0	0.0	0.00	1.0e+00	AKTIP
Friendships satisfaction	1.16	1	0	0.0	0.00	1.0e+00	C18orf8
Qualifications: nursing, teaching	1.09	1	1	2.2	0.00	1.0e+00	NEGR1
Medication for cholesterol	1.63	2	2	4.4	0.00	1.0e+00	ATG7 NTN5
Asthma (self-reported)	1.45	3	0	0.0	-0.20	8.0e-01	IQCH MAP2K5 NHP2L1
Smoking status: Current	1.99	3	0	0.0	0.00	1.0e+00	AMAC1L2 C1QTNF4 TDH
Forced expiratory volume in 1-second (FEV1), predicted percentage	1.40	2	1	2.2	0.00	1.0e+00	RP11-347C12.2 SH2B1
Whole body water mass	3.81	53	37	82.2	0.86	1.1e-19	AC092159.2 ACSM5 ADCY9 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C18orf8 C3orf38 C6orf142 CADM2 CERS5 CREB1 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM86B3P FGFR4 FLT3 FRS3 FTO GPRC5B GTF3A IQCH-AS1 KANSL1 LBXCOR1 LIN7C MADD MC4R METTL15 MSRA NADK NCOA1 NEGR1 ORAOV1 PINX1 PM20D1 POLK RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SH2B1 SSBP3 TEAD3 TM2D1 TMEM160 TMEM18 TTC26 UHRF1BP1
Leg predicted mass (right)	4.58	56	42	93.3	0.91	2.2e-29	AC092159.2 ACSM5 ADCY9 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 AMAC1L2 C11orf24 C18orf8 C3orf38 C6orf142 CADM2 CERS5 CREB1 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM86B3P FLT3 FNBP4 FRS3 FTO GPRC5B GTF3A IQCH IQCH-AS1 KANSL1 LBXCOR1 LIN7C MADD MAP2K5 MC4R METTL15 MSRA NADK NCOA1 NEGR1 ORAOV1 PHF2 PM20D1 POLK RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 SSBP3 TEAD3 TM2D1 TMEM18 TTC26 UHRF1BP1
Arm fat mass (left)	6.69	63	46	102.2	0.95	3.9e-41	AC092159.2 ACP2 ACSM5 ADCY3 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 AMAC1L2 BTBD12 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CREB1 DHRS11 DNAJC11 DTX2P1-UPK3BP1-PMS2P11 EFR3B FAIM2 FAM86B3P FLJ10661 FLT3 FNBP4 FRS3 FTO GPRC5B GTF3A IQCH IQCH-AS1 KANSL1 LBXCOR1 LIN7C MADD MAP2K5 MC4R METTL15 MFHAS1 MSRA NADK NEGR1 ORAOV1 PIK3C3 POLK POMC PTPMT1 RASA2 RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 SRR SSBP3 TEAD3 TM2D1 TMEM18 TYW3 UHRF1BP1
Number of self-reported non-cancer illnesses	1.77	5	2	4.4	0.68	1.3e-01	IQCH IQCH-AS1 MAP2K5 NEGR1 NTN5
Miserableness	2.59	13	6	13.3	-0.99	5.8e-11	AC087269.1 AF131215.2 AF131215.9 AMAC1L2 FAM120AOS FAM86B3P FLJ10661 FNBP4 MADD MFHAS1 MSRA PTPMT1 SGK223
Guilty feelings	2.75	7	1	2.2	-0.70	5.1e-02	AF131215.9 AMAC1L2 FLJ10661 FNBP4 LIN28B MFHAS1 SGK223
Commuting to job workplace: Public transport	1.50	1	0	0.0	0.00	1.0e+00	NEGR1
Medication: Blood pressure	2.11	7	1	2.2	0.56	1.5e-01	AF131215.9 AMAC1L2 ATG7 CRIP3 MFHAS1 NTN5 SGK223
High cholesterol (Self-reported)	1.73	2	2	4.4	0.00	1.0e+00	NTN5 POLK
Medication: Bendroflumethiazide	2.19	4	1	2.2	0.72	1.7e-01	AF131215.9 AMAC1L2 NTN5 SGK223
Ever smoked	2.04	5	1	2.2	0.57	3.2e-01	CADM2 CSPG5 IQCH-AS1 MAP2K5 SRR
Basal metabolic rate	4.22	59	39	86.7	0.86	4.5e-23	AC092159.2 ACSM5 ADCY9 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C18orf8 C3orf38 C6orf142 CADM2 CERS5 CREB1 DHRS11 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM86B3P FGFR4 FLT3 FRS3 FTO GPRC5B GTF3A IQCH IQCH-AS1 KANSL1 LBXCOR1 LIN28B LIN7C MADD MAP2K5 MC4R METTL15 MSRA NADK NCOA1 NEGR1 ORAOV1 PINX1 PM20D1 POLK POMC RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 SSBP3 TEAD3 TM2D1 TMEM160 TMEM18 TTC26 UHRF1BP1
Leg fat percentage (left)	4.92	41	26	57.8	0.95	4.0e-27	ACP2 ADCY3 AF131215.9 AKTIP C18orf8 C1QTNF4 C3orf38 CADM2 CALCRL CERS5 DHRS11 DNAJC11 DTX2P1-UPK3BP1-PMS2P11 EFR3B FAIM2 FAM228B FLJ10661 FNBP4 FTO GTF3A IQCH IQCH-AS1 LBXCOR1 LIN7C MADD MAP2K5 MC4R METTL15 MFHAS1 NEGR1 PIK3C3 POLK POMC PTPMT1 RASA2 RASAL2-AS1 RP11-347C12.2 RP11-462G12.1 SGK223 SH2B1 UHRF1BP1
Arm fat-free mass (left)	3.96	52	36	80.0	0.83	6.2e-17	AC092159.2 ACSM5 ADCY9 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C18orf8 C3orf38 CADM2 CERS5 CREB1 DHRS11 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FGFR4 FLT3 FRS3 FTO GPR1 GPRC5B GTF3A IQCH-AS1 LBXCOR1 LIN7C MADD MAP2K5 MC4R METTL15 MSRA NADK NCOA1 NEGR1 ORAOV1 PINX1 PM20D1 POLK RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SH2B1 SSBP3 TEAD3 TM2D1 TMEM160 TMEM18 UHRF1BP1
Average weekly beer plus cider intake	2.36	5	0	0.0	-0.74	9.0e-02	AF131215.9 FAM86B3P FGFR1 MFHAS1 MSRA
Irritability	2.80	9	9	20.0	-0.99	1.9e-08	AC087269.1 AF131215.2 AF131215.9 AMAC1L2 FAM86B3P FLJ10661 MFHAS1 MSRA SGK223
Risk taking	2.00	4	1	2.2	0.95	4.7e-02	AF131215.2 AF131215.9 AMAC1L2 CADM2
Fractured/broken bones in last 5 years	1.89	2	0	0.0	0.00	1.0e+00	IQCH TUBA1C
Diastolic blood pressure, automated reading	2.41	19	12	26.7	0.46	3.8e-02	AC087269.1 ADSL AF131215.2 AF131215.9 AMAC1L2 CERS5 CSPG5 FAM86B3P FLJ10661 FNBP4 MECR MFHAS1 MSRA PINX1 RP11-462G12.1 SGK223 SMARCD1 SRR TMEM127
Vascular/heart problems diagnosed by doctor	2.54	18	6	13.3	-0.70	1.2e-04	ACP2 AF131215.2 AF131215.9 ATG7 CRIP3 DNAJC11 FAM86B3P IQCH IQCH-AS1 MADD MAP2K5 MFHAS1 MSRA NEGR1 NTN5 RP11-347C12.2 SGK223 SRR
Cholesterol lowering medication	1.30	2	2	4.4	0.00	1.0e+00	NTN5 POLK
Alcohol drinker status: Previous	1.15	1	0	0.0	0.00	1.0e+00	RASSF1
Impedance of whole body	5.68	70	49	108.9	-0.90	5.9e-31	AC092159.2 ACSM5 ADCY3 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 AMAC1L2 AMIGO1 BTBD12 C11orf24 C6orf142 C9orf130 CADM2 CERS5 CLOCK CREB1 DHRS11 DNAJC16 DTX2P1-UPK3BP1-PMS2P11 EFR3B EP300 FAIM2 FAM86B3P FLJ10661 FLT3 FRS3 FTO GPR1 GPRC5B GTF3A HAPLN4 IQCH-AS1 LBXCOR1 LIMA1 LIN28B LIN7C LMBR1L MAP2K5 MAP3K11 MC4R METTL15 MFHAS1 MSRA NADK NEGR1 NHP2L1 ORAOV1 PINX1 PM20D1 POLK POMC RASAL2-AS1 RASSF1 RIT1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH3YL1 SMARCD1 SREK1IP1 TDH TEAD3 TMEM160 TMEM18 TTC26 TYW3 UHRF1BP1
Leg fat mass (left)	6.24	54	38	84.4	0.94	6.7e-34	AC092159.2 ACP2 ACSM5 ADCY3 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CREB1 DHRS11 DNAJC11 DTX2P1-UPK3BP1-PMS2P11 EFR3B FAIM2 FLJ10661 FLT3 FNBP4 FTO GPRC5B GTF3A IQCH IQCH-AS1 LBXCOR1 LIN7C MADD MAP2K5 MC4R METTL15 MFHAS1 MSRA NADK NEGR1 PIK3C3 POLK POMC PTPMT1 RASA2 RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 TEAD3 TM2D1 TMEM18 UHRF1BP1
Arm predicted mass (left)	3.91	53	38	84.4	0.84	1.5e-17	AC092159.2 ACSM5 ADCY9 ADSL AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C18orf8 C3orf38 CADM2 CERS5 CREB1 DHRS11 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FGFR4 FLT3 FRS3 FTO GPR1 GPRC5B GTF3A IQCH-AS1 LBXCOR1 LIN7C MC4R METTL15 MSRA NADK NCOA1 NEGR1 ORAOV1 PINX1 PM20D1 POLK RASAL2-AS1 RASSF1 RP11-347C12.2 RP11-462G12.1 RP11-568K15.1 SGK223 SH2B1 SH3YL1 SSBP3 TEAD3 TM2D1 TMEM160 TMEM18 TTC26 UHRF1BP1

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Adipose Subcutaneous	46	1.32	3.0
GTEx	Adipose Visceral Omentum	22	1.08	2.9
GTEx	Adrenal Gland	14	0.96	2.9
GTEx	Artery Aorta	41	1.38	2.9
GTEx	Artery Coronary	11	0.93	2.8
GTEx	Artery Tibial	46	1.22	3.0
GTEx	Brain Caudate basal ganglia	8	0.87	3.0
GTEx	Brain Cerebellar Hemisphere	14	0.94	2.8
GTEx	Brain Cerebellum	20	1.01	2.8
GTEx	Brain Cortex	15	1.45	3.2
GTEx	Brain Frontal Cortex BA9	12	1.30	3.1
GTEx	Brain Hippocampus	5	0.95	2.9
GTEx	Brain Hypothalamus	5	0.85	2.9
GTEx	Brain Nucleus accumbens basal ganglia	10	1.16	2.8
GTEx	Brain Putamen basal ganglia	6	0.96	2.8
GTEx	Breast Mammary Tissue	24	1.22	2.9
GTEx	Breast Mammary Tissue (Male)	12	1.01	2.8
GTEx	Breast Mammary Tissue (Female)	15	0.91	2.8
GTEx	Cells EBV-transformed lymphocytes	13	0.91	3.3
GTEx	Cells Transformed fibroblasts	37	0.88	2.8
GTEx	Colon Sigmoid	10	0.68	2.7
GTEx	Colon Transverse	23	1.11	2.9
GTEx	Esophagus Gastroesophageal Junction	17	1.18	2.9
GTEx	Esophagus Mucosa	32	0.96	2.8
GTEx	Esophagus Muscularis	41	1.27	2.9
GTEx	Heart Atrial Appendage	21	1.33	2.9
GTEx	Heart Left Ventricle	22	1.44	3.2
GTEx	Liver	6	0.84	3.0
GTEx	Lung	40	1.39	3.0
GTEx	Muscle Skeletal	35	1.21	2.8
GTEx	Nerve Tibial	44	1.02	3.0
GTEx	Ovary	14	1.54	3.4
GTEx	Pancreas	17	1.04	2.8
GTEx	Pituitary	13	1.17	3.0
GTEx	Prostate	12	1.44	3.2
GTEx	Skin Not Sun Exposed Suprapubic	30	1.22	2.8
GTEx	Skin Sun Exposed Lower leg	42	1.15	2.8
GTEx	Small Intestine Terminal Ileum	7	1.52	3.2
GTEx	Spleen	14	0.99	3.1
GTEx	Stomach	16	1.10	2.9
GTEx	Testis	32	1.01	2.9
GTEx	Thyroid	38	0.95	2.7
GTEx	Uterus	7	1.23	3.2
GTEx	Vagina	11	1.73	3.2
GTEx	Whole Blood	20	1.00	3.4
METSIM	Adipose	30	0.65	2.5
NTR	Blood	19	0.79	2.6
ROSMAP	Brain Pre-frontal Cortex	57	1.30	3.0
YFS	Blood	30	0.65	2.5
CommonMind	Brain Pre-frontal Cortex	49	0.91	2.8
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	13	0.79	2.8
The Cancer Genome Atlas	Breast Invasive Carcinoma	34	0.77	2.6
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	11	1.00	2.6
The Cancer Genome Atlas	Colon Adenocarcinoma	19	0.92	2.7
The Cancer Genome Atlas	Esophageal Carcinoma	6	0.88	2.5
The Cancer Genome Atlas	Glioblastoma Multiforme	9	0.88	2.7
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	22	0.81	2.6
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	30	0.73	2.6
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	14	0.68	2.5
The Cancer Genome Atlas	Brain Lower Grade Glioma	27	0.63	2.6
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	9	0.81	2.6
The Cancer Genome Atlas	Lung Adenocarcinoma	23	0.78	2.6
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	19	0.76	2.5
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	15	0.94	2.6
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	14	0.84	2.6
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	8	0.60	2.7
The Cancer Genome Atlas	Prostate Adenocarcinoma	28	0.61	2.5
The Cancer Genome Atlas	Rectum Adenocarcinoma	4	0.58	2.4
The Cancer Genome Atlas	Soft Tissue Sarcoma	13	1.22	2.6
The Cancer Genome Atlas	Skin Cutaneous Melanoma	3	0.56	2.4
The Cancer Genome Atlas	Stomach Adenocarcinoma	11	0.65	2.6
The Cancer Genome Atlas	Testicular Germ Cell Tumors	13	1.02	2.6
The Cancer Genome Atlas	Thyroid Carcinoma	40	0.78	2.5
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	2	0.39	2.7